Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma
出版年份 2019 全文链接
标题
Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma
作者
关键词
-
出版物
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 1374-1383
出版商
Informa UK Limited
发表日期
2019-04-12
DOI
10.1080/21691401.2019.1596943
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combined Treatment for Lung Metastasis from Hepatocellular Carcinoma: A Case Report
- (2018) Hee-jae Jang et al. Explore-The Journal of Science and Healing
- Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
- (2018) Xingmei Duan et al. International Journal of Nanomedicine
- Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques
- (2018) Yi Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Tumor microenvironment dual-responsive core–shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA
- (2017) Tianqi Wang et al. International Journal of Nanomedicine
- Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes
- (2017) Jibin Guan et al. Nanoscale
- Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
- (2016) Manju Kanamala et al. BIOMATERIALS
- Highly efficient siRNA delivery from core–shell mesoporous silica nanoparticles with multifunctional polymer caps
- (2016) Karin Möller et al. Nanoscale
- Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer
- (2015) Dawen Dong et al. CANCER LETTERS
- Life in 3D is never flat: 3D models to optimise drug delivery
- (2015) Kathleen A. Fitzgerald et al. JOURNAL OF CONTROLLED RELEASE
- Sequential Intra-Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
- (2014) Caoyun Ju et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas
- (2014) Zhen-Zhen Yang et al. BIOMATERIALS
- Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers
- (2014) Vasilios Tsouris et al. BIOTECHNOLOGY ADVANCES
- Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids
- (2014) Michael G. Wientjes et al. JOURNAL OF CONTROLLED RELEASE
- Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA
- (2014) Jianan Shen et al. MOLECULAR PHARMACEUTICS
- Enhancing endosomal escape for nanoparticle mediated siRNA delivery
- (2014) Da Ma Nanoscale
- The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations
- (2014) Zixiu Du et al. Scientific Reports
- Predictive Models of Diffusive Nanoparticle Transport in 3-Dimensional Tumor Cell Spheroids
- (2013) Yue Gao et al. AAPS Journal
- Lipid-based nanoparticles in the systemic delivery of siRNA
- (2013) Qiaoya Lin et al. Nanomedicine
- The Emperor of All Maladies: A Biography of Cancer. Written by Siddhartha Mukherjee. Scribner, New York, 2011. 608pp. Price: $18.00 (US), £9.99 (UK). ISBN 978-1439170915.
- (2012) David P. Yuppa PSYCHO-ONCOLOGY
- The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells
- (2009) Yin-Lin Ge et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More